GE HealthCare Technologies Inc.

10-K & 10-Q Filings

GE HealthCare Technologies Inc. is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator. The company is dedicated to creating a world where healthcare has no limits. Its business strategy includes the acquisition of technologies and businesses that expand or complement its existing business. GE HealthCare operates in four business segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The company's Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions for various clinical specialties. The Ultrasound segment provides solutions for screening, diagnosis, treatment, and monitoring of certain diseases across five clinical areas: Radiology and Primary Care, Women's Health, Cardiovascular, Point of Care and Handheld, and Surgical Visualization and Guidance. The Patient Care Solutions segment offers medical devices, consumables, services, and digital solutions that acquire and transform complex clinical data into real-time visualization and clinical decision support. The Pharmaceutical Diagnostics segment is a leading supplier of diagnostic agents to the global radiology and nuclear medicine industry. GE HealthCare's website is [www.gehealthcare.com], and its ticker symbol is "GEHC" on the NASDAQ stock exchange.

12 mos ending Dec 31, 20233 mos ending Mar 31, 20233 mos ending Mar 31, 2024CAGR %YoY %Revenue (+)
$19552.00
4707.00
4650.00
-1.21%Cost of Revenue (-)
$11630.00
2816.00
2749.00
-2.38%Gross Profit (+)
$7922.00
1891.00
1902.00
0.58%Selling, General & Administrative (-)
$4282.00
1062.00
1038.00
-2.26%Research & Development (-)
$1205.00
270.00
324.00
20.00%Operating Expenses (-)
$5487.00
1332.00
1362.00
2.25%Costs & Expenses (Total) (-)
$17117.00
4148.00
4111.00
-0.89%Operating Income/Loss (+)
$2435.00
559.00
540.00
-3.40%Non-operating Income/Expense (+)
$468.00
123.00
94.00
-23.58%Earnings before Tax (+)
$2361.00
546.00
512.00
-6.23%Tax Expense (-)
$743.00
163.00
124.00
-23.93%Income/Loss (Continuing Operations) (+)
$1618.00
383.00
388.00
1.31%Income/Loss (Discontinued Operations) (+)
$-4.00
Profit/Loss (+)
$1614.00
383.00
388.00
1.31%Net Income/Loss (NCI) (-)
$46.00
11.00
14.00
27.27%Net Income/Loss (+)
$1568.00
372.00
374.00
0.54%Preferred & Other Distributions (-)
$183.00
183.00
Net Income/Loss (Common) (+)
$1385.00
189.00
374.00
97.88%EPS (Basic)
$3.05
0.42
0.82
95.24%EPS (Diluted)
$3.03
0.41
0.81
97.56%Weighted Avg Shares (Basic)
455.00
454.00
456.00
0.44%Weighted Avg Shares (Diluted)
458.00
457.00
459.00
0.44%Receivables
$3557.00
3404.00
3344.00
-1.76%Inventory
$1960.00
2256.00
1989.00
-11.84%Other Assets (Current)
$3893.00
3944.00
4041.00
2.46%Assets (Current)
$9410.00
9604.00
9373.00
-2.41%Goodwill & Intangibles
$14189.00
14418.00
14101.00
-2.20%Other Assets
$8855.00
8615.00
8736.00
1.40%Assets (Non-current)
$23044.00
23033.00
22837.00
-0.85%Assets (Total)
$32454.00
32637.00
32208.00
-1.31%Accounts Payable
$2947.00
2977.00
2931.00
-1.55%Debt (Current)
$1006.00
5.00
1008.00
20060.00%Other Liabilities (Current)
$5028.00
5254.00
4920.00
-6.36%Liabilities (Current)
$8981.00
8236.00
8859.00
7.56%Debt (Non-current)
$8436.00
10234.00
8247.00
-19.42%Other Liabilities
$7727.00
7270.00
7504.00
3.22%Liabilities (Non-current)
$16163.00
17504.00
15751.00
-10.01%Liabilities (Total)
$25144.00
25740.00
24609.00
-4.39%Retained Earnings
$1326.00
185.00
1687.00
811.89%AOCI
$-691.00
75.00
-787.00
-1149.33%Shareholder's Equity
$7145.00
6696.00
7423.00
10.86%Liabilities & Equity
$32454.00
32637.00
32208.00
-1.31%Net Income/Loss
$1614.00
383.00
388.00
1.31%Depreciation & Amortization
$610.00
157.00
148.00
-5.73%Increase/Decrease in Working Capital
$131.00
-85.00
-154.00
-81.18%Share-based Compensation
$-218.00
-77.00
-56.00
27.27%Adjustments to Reconcile Net Income
$487.00
85.00
31.00
-63.53%Net Cash (Operating)
$2101.00
468.00
419.00
-10.47%Capital Expenditure
$533.00
270.00
145.00
-46.30%Net Cash (Investing)
$-558.00
-266.00
-188.00
29.32%Increase/Decrease in Debt
$1139.00
1985.00
-151.00
-107.61%Interest Expenses
$570.00
42.00
55.00
30.95%Dividends Paid
$41.00
14.00
Net Cash (Financing)
$-478.00
673.00
-153.00
-122.73%Cash Taxes Paid
$474.00
102.00
86.00
-15.69%Effect of Exchange Rate
$-10.00
8.00
-19.00
-337.50%Increase/Decrease in Cash
$1055.00
883.00
59.00
-93.32%Cash (Beginning)
$1451.00
1451.00
2506.00
72.71%Cash (Ending)
$2506.00
2334.00
2565.00
9.90%NOPAT
$1946.14
454.57
449.30
-1.16%Gross Margin %
40.52%
40.17%
40.90%
Operating Margin %
12.45%
11.88%
11.61%
NOPAT Margin %
9.95%
9.66%
9.66%
Net Margin %
8.02%
7.90%
8.04%
Tax Rate %
20.08%
18.68%
16.80%
ROA
6.00%
1.39%
1.39%
ROE
27.24%
6.79%
6.05%
ROIC
13.72%
3.15%
3.19%
Asset Turnover
0.60
0.14
0.14
Inventory Turnover
5.93
1.25
1.38
Equity Multiplier
4.54
4.87
4.34
Current Ratio
1.05
1.17
1.06
Quick Ratio
0.40
0.41
0.38
Debt/Equity Ratio
1.32
1.53
1.25
Interest Coverage Ratio
4.27
13.31
9.82
R&D/Sales
0.06
0.06
0.07
Dividend Payout Ratio %
2.11%
3.12%
Total Payout
$-528.00
-1943.00
220.00
111.32%Payout Ratio %
-27.13%
-427.44%
48.97%